Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

ClinicalTrials.gov ID: NCT04534959

Public ClinicalTrials.gov record NCT04534959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in critically injured patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.

Study identification

NCT ID
NCT04534959
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
6,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2020 (Actual)
Primary completion
Nov 15, 2022 (Actual)
Completion
Jun 30, 2025 (Estimated)
Last update posted
Apr 2, 2025

2020 – 2025

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
University of Alabama-Birmingham Medical Center Birmingham Alabama 35294 —
Denver Health Denver Colorado 80204 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
Oregon Health and Sciences University Portland Oregon 97239 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15224 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Brooke Army Medical Center Fort Sam Houston Texas 78234 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04534959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04534959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →